产品中心 抗体 其他一抗

所有图片(1/5)

CDK8 Recombinant Rabbit mAb (S-1627-70)

Cyclin-dependent kinase 8,Cell division protein kinase 8,Mediator complex subunit CDK8,Mediator of RNA polymerase II transcription subunit CDK8,Protein kinase K35

价格 600.00 供应商现货 : 3-5个工作日
货号 S0B1310
规格
数量
收藏 分享

产品介绍 FAQs 评论(0)

产品规格
  • 宿主来源

    Rabbit
  • 抗原名称

    CDK8
  • 分子别名

    Cyclin-dependent kinase 8; Cell division protein kinase 8; Mediator complex subunit CDK8; Mediator of RNA polymerase II transcription subunit CDK8; Protein kinase K35
  • 免疫原

    Recombinant Protein
  • 细胞定位

    Nucleus
  • Accession

    P49336
  • 克隆号

    S-1627-70
  • 抗体类型

    Recombinant mAb
  • 抗体同种型

    IgG
  • 反应种属 ?

    Hu, Ms, Rt
  • 阳性样本

    K562, SW480, HCT 116, HT-29, HeLa, NIH/3T3, RAW264.7, mouse testis, rat testis
  • 预测反应种属
    (反应种属缩写表)

    Sq, Mk, C. aethiops, Rb
  • 纯化方式

    Protein A
  • 浓度

    0.5 mg/ml
  • 标记

    Unconjugated
  • 性状

    Liquid
  • 缓冲体系

    PBS, 40% Glycerol, 0.05% BSA, 0.03% Proclin 300

  • 储存条件

    12 months from date of receipt / reconstitution, -20 °C as supplied

  • 应用

    ICFCM

    ICC ?

    WB

  • 稀释度

    应用 稀释度 推荐种属
    WB 1:1000 Hu, Ms, Rt
    ICC 1:500 Hu
    ICFCM 1:50 Hu
背景介绍
  • CDK8 (cyclin-dependent kinase 8) is a serine/threonine kinase that plays a crucial role in regulating DNA transcription and cell cycle progression. It forms a module with Cyclin C (CCNC), Med12, and Med13, which associates with the Mediator complex to modulate gene transcription. CDK8 phosphorylates the C-terminal domain of RNA polymerase II, influencing transcriptional elongation. In cancer, CDK8 acts as a positive regulator of oncogene-induced proliferation by recruiting pTEF-B and BRD4 to oncogenic genes, promoting efficient transcriptional elongation. However, it can also inhibit Mediator-dependent super-enhancer driven transcription in acute myeloid leukemia (AML), suggesting its role may vary depending on the oncogenic context. Additionally, CDK8 is often amplified in colorectal cancer, where it modulates beta-catenin activity, contributing to tumor progression.

  • 免疫印迹

    • WB result of CDK8 Recombinant Rabbit mAb
      Primary antibody: CDK8 Recombinant Rabbit mAb at 1/1000 dilution
      Lane 1: K562 whole cell lysate 20 µg
      Lane 2: SW480 whole cell lysate 20 µg
      Lane 3: HCT 116 whole cell lysate 20 µg
      Lane 4: HT-29 whole cell lysate 20 µg
      Lane 5: HeLa whole cell lysate 20 µg
      Secondary antibody: Goat Anti-rabbit IgG, (H+L), HRP conjugated at 1/10000 dilution
      Predicted MW: 53 kDa
      Observed MW: 55 kDa

    • WB result of CDK8 Recombinant Rabbit mAb
      Primary antibody: CDK8 Recombinant Rabbit mAb at 1/1000 dilution
      Lane 1: NIH/3T3 whole cell lysate 20 µg
      Lane 2: RAW264.7 whole cell lysate 20 µg
      Lane 3: mouse testis lysate 20 µg
      Secondary antibody: Goat Anti-rabbit IgG, (H+L), HRP conjugated at 1/10000 dilution
      Predicted MW: 53 kDa
      Observed MW: 55 kDa

    • WB result of CDK8 Recombinant Rabbit mAb
      Primary antibody: CDK8 Recombinant Rabbit mAb at 1/1000 dilution
      Lane 1: rat testis lysate 20 µg
      Secondary antibody: Goat Anti-rabbit IgG, (H+L), HRP conjugated at 1/10000 dilution
      Predicted MW: 53 kDa
      Observed MW: 55 kDa

  • 流式分析

    • Flow cytometric analysis of HCT116 (Human colorectal carcinoma epithelial cell) labelling CDK8 antibody at 1/50 dilution (1 μg) / (Red) compared with a Rabbit monoclonal IgG (Black) isotype control and an unlabelled control (cells without incubation with primary antibody and secondary antibody) (Blue). Goat Anti - Rabbit IgG Alexa Fluor® 488 was used as the secondary antibody.

  • 免疫细胞化学

    • ICC shows positive staining in HCT116 cells. Anti- CDK8 antibody was used at 1/500 dilution (Green) and incubated overnight at 4°C. Goat polyclonal Antibody to Rabbit IgG - H&L (Alexa Fluor® 488) was used as secondary antibody at 1/1000 dilution. The cells were fixed with 4% PFA and permeabilized with 0.1% PBS-Triton X-100. Nuclei were counterstained with DAPI (Blue). Counterstain with tubulin (Red).

FAQs

斯达特公司的抗体,可以回收利用几次?

我们一般不推荐客户回收利用抗体。 因为抗体使用之后缓冲体系已经发生改变,不同客户在回收抗体的保存条件上也会有差异,所以抗体回收使用效果无法保证。另外,我们对一批抗体回收验证测试,测试结果显示不同抗体可回收次数不同,一般效价越高的抗体,可重复使用的次数越多,客户可根据实验情况来确定

评论(0)